Healthcare >> Analyst Interviews >> September 20, 2010

Predictions Of A Medtech Buy Rally – Dr. Sean Lavin, M.d. – Lazard Capital Markets

Dr. Sean Lavin, M.D., is a Senior Analyst who covers the medical technology space. He joined Lazard Capital Markets in March 2008. Prior to joining Lazard Capital Markets, Dr. Lavin was a sell-side Analyst at Oppenheimer & Co., where he covered medical devices and diagnostics. He focuses on minimally invasive devices and those which he believes can change the standard of care. Prior to joining Oppenheimer, Dr. Lavin worked as a Surgical Resident at Mount Sinai Medical Center, in Miami Beach, Fla. While there, he participated in general, plastic, trauma, vascular, cardiothoracic and urologic surgery cases, and he cared for patients in the ICU, emergency room and burn unit. Dr. Lavin has an M.D. from the Ohio State University College of Medicine and a B.S. in chemistry with a minor in biology and a concentration in economics from the Massachusetts Institute of Technology. Profile
TWST: What is your take on the economy and on the medical devices sector?

Dr. Lavin: My overall take is that the sentiment on Wall Street, which is extraordinarily negative on at least medical